Cargando…

Effect of Hypochlorous Acid on Blepharitis through Ultrasonic Atomization: A Randomized Clinical Trial

Purpose: To evaluate the efficacy and safety of eyelid hygiene using topical 0.01% hypochlorous acid (HOCL) through ultrasonic atomization after 2 weeks in patients with blepharitis. Design: Randomized controlled trial. Methods: Patients with blepharitis were randomized into two groups: topical 0.01...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hong, Wu, Yuqing, Wan, Xichen, Shen, Yan, Le, Qihua, Yang, Pei, Zhou, Shuyun, Zhou, Xujiao, Zhou, Feng, Gu, Hao, Hong, Jiaxu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917691/
https://www.ncbi.nlm.nih.gov/pubmed/36769811
http://dx.doi.org/10.3390/jcm12031164
_version_ 1784886428783607808
author Zhang, Hong
Wu, Yuqing
Wan, Xichen
Shen, Yan
Le, Qihua
Yang, Pei
Zhou, Shuyun
Zhou, Xujiao
Zhou, Feng
Gu, Hao
Hong, Jiaxu
author_facet Zhang, Hong
Wu, Yuqing
Wan, Xichen
Shen, Yan
Le, Qihua
Yang, Pei
Zhou, Shuyun
Zhou, Xujiao
Zhou, Feng
Gu, Hao
Hong, Jiaxu
author_sort Zhang, Hong
collection PubMed
description Purpose: To evaluate the efficacy and safety of eyelid hygiene using topical 0.01% hypochlorous acid (HOCL) through ultrasonic atomization after 2 weeks in patients with blepharitis. Design: Randomized controlled trial. Methods: Patients with blepharitis were randomized into two groups: topical 0.01% HOCL through ultrasonic atomization (HOCL group, 42 eyes) or eyelid scrubs (control group, 37 eyes). Patients in both groups received warm compresses twice daily and topical 0.5% levofloxacin three times a day. Primary outcomes were the ocular surface disease index scores (OSDI), lid margin redness, lid margin abnormalities, meibum expressibility, meibum quality, and noninvasive breakup time after 2 weeks. Secondary outcomes were conjunctiva redness, corneal fluorescein staining, and tear meniscus height. A questionnaire of treatment adherence with a free response section was administered to confirm patient compliance and comments. Results: Sixty-seven participants participated in this study. Both groups show an improvement in all primary outcomes, while statistically significant improvements in OSDI, lid margin redness, lid margin abnormality, meibum expressibility and quality are only limited to the HOCL group after 2 weeks of treatment (p < 0.05, p < 0.05, p < 0.001, p < 0.001 and p < 0.001, respectively). Subgroup analysis in HOCL reveals that only the change in lid margin abnormality and meibum expressibility in the mild–moderate meibomian glands loss patients at baseline has a statistically significant difference p < 0.05). Multiple linear regression shows that the improvement in OSDI is negatively associated with meibum expressibility score at the baseline (95% CI [−28.846, −1.815], p = 0.028). The patient compliance is 7.1 ± 2.0 in the HOCL group and 7.1 ± 1.8 in the control group (p > 0.05). No adverse events are reported. Conclusion: Topical 0.01% HOCL through ultrasonic atomization is a tolerable and effective eyelid hygiene treatment for blepharitis.
format Online
Article
Text
id pubmed-9917691
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99176912023-02-11 Effect of Hypochlorous Acid on Blepharitis through Ultrasonic Atomization: A Randomized Clinical Trial Zhang, Hong Wu, Yuqing Wan, Xichen Shen, Yan Le, Qihua Yang, Pei Zhou, Shuyun Zhou, Xujiao Zhou, Feng Gu, Hao Hong, Jiaxu J Clin Med Article Purpose: To evaluate the efficacy and safety of eyelid hygiene using topical 0.01% hypochlorous acid (HOCL) through ultrasonic atomization after 2 weeks in patients with blepharitis. Design: Randomized controlled trial. Methods: Patients with blepharitis were randomized into two groups: topical 0.01% HOCL through ultrasonic atomization (HOCL group, 42 eyes) or eyelid scrubs (control group, 37 eyes). Patients in both groups received warm compresses twice daily and topical 0.5% levofloxacin three times a day. Primary outcomes were the ocular surface disease index scores (OSDI), lid margin redness, lid margin abnormalities, meibum expressibility, meibum quality, and noninvasive breakup time after 2 weeks. Secondary outcomes were conjunctiva redness, corneal fluorescein staining, and tear meniscus height. A questionnaire of treatment adherence with a free response section was administered to confirm patient compliance and comments. Results: Sixty-seven participants participated in this study. Both groups show an improvement in all primary outcomes, while statistically significant improvements in OSDI, lid margin redness, lid margin abnormality, meibum expressibility and quality are only limited to the HOCL group after 2 weeks of treatment (p < 0.05, p < 0.05, p < 0.001, p < 0.001 and p < 0.001, respectively). Subgroup analysis in HOCL reveals that only the change in lid margin abnormality and meibum expressibility in the mild–moderate meibomian glands loss patients at baseline has a statistically significant difference p < 0.05). Multiple linear regression shows that the improvement in OSDI is negatively associated with meibum expressibility score at the baseline (95% CI [−28.846, −1.815], p = 0.028). The patient compliance is 7.1 ± 2.0 in the HOCL group and 7.1 ± 1.8 in the control group (p > 0.05). No adverse events are reported. Conclusion: Topical 0.01% HOCL through ultrasonic atomization is a tolerable and effective eyelid hygiene treatment for blepharitis. MDPI 2023-02-01 /pmc/articles/PMC9917691/ /pubmed/36769811 http://dx.doi.org/10.3390/jcm12031164 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Zhang, Hong
Wu, Yuqing
Wan, Xichen
Shen, Yan
Le, Qihua
Yang, Pei
Zhou, Shuyun
Zhou, Xujiao
Zhou, Feng
Gu, Hao
Hong, Jiaxu
Effect of Hypochlorous Acid on Blepharitis through Ultrasonic Atomization: A Randomized Clinical Trial
title Effect of Hypochlorous Acid on Blepharitis through Ultrasonic Atomization: A Randomized Clinical Trial
title_full Effect of Hypochlorous Acid on Blepharitis through Ultrasonic Atomization: A Randomized Clinical Trial
title_fullStr Effect of Hypochlorous Acid on Blepharitis through Ultrasonic Atomization: A Randomized Clinical Trial
title_full_unstemmed Effect of Hypochlorous Acid on Blepharitis through Ultrasonic Atomization: A Randomized Clinical Trial
title_short Effect of Hypochlorous Acid on Blepharitis through Ultrasonic Atomization: A Randomized Clinical Trial
title_sort effect of hypochlorous acid on blepharitis through ultrasonic atomization: a randomized clinical trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917691/
https://www.ncbi.nlm.nih.gov/pubmed/36769811
http://dx.doi.org/10.3390/jcm12031164
work_keys_str_mv AT zhanghong effectofhypochlorousacidonblepharitisthroughultrasonicatomizationarandomizedclinicaltrial
AT wuyuqing effectofhypochlorousacidonblepharitisthroughultrasonicatomizationarandomizedclinicaltrial
AT wanxichen effectofhypochlorousacidonblepharitisthroughultrasonicatomizationarandomizedclinicaltrial
AT shenyan effectofhypochlorousacidonblepharitisthroughultrasonicatomizationarandomizedclinicaltrial
AT leqihua effectofhypochlorousacidonblepharitisthroughultrasonicatomizationarandomizedclinicaltrial
AT yangpei effectofhypochlorousacidonblepharitisthroughultrasonicatomizationarandomizedclinicaltrial
AT zhoushuyun effectofhypochlorousacidonblepharitisthroughultrasonicatomizationarandomizedclinicaltrial
AT zhouxujiao effectofhypochlorousacidonblepharitisthroughultrasonicatomizationarandomizedclinicaltrial
AT zhoufeng effectofhypochlorousacidonblepharitisthroughultrasonicatomizationarandomizedclinicaltrial
AT guhao effectofhypochlorousacidonblepharitisthroughultrasonicatomizationarandomizedclinicaltrial
AT hongjiaxu effectofhypochlorousacidonblepharitisthroughultrasonicatomizationarandomizedclinicaltrial